299. 嚢胞性線維症 Cystic fibrosis Clinical trials / Disease details

臨床試験数 : 1,695 / 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05530278 (ClinicalTrials.gov)	September 20, 2022	5/9/2022	A Study to Assess the Pharmacokinetics and Safety of Co-administered Oral Galicaftor, Navocaftor, an ...	Assessment of Multiple-Dose Pharmacokinetics and Safety of the Co-administration of Galicaftor, Navo ...	Healthy Volunteers	Drug: Galicaftor;Drug: ABBV-576;Drug: Navocaftor;Drug: Midazolam	AbbVie	NULL	Completed	18 Years	65 Years	Female	24	Phase 1	United States
2	NCT01060566 (ClinicalTrials.gov)	February 2010	29/1/2010	Study of VX-770 on Midazolam and Rosiglitazone and the Effect of Fluconazole on VX-770	An Open-Label Phase 1 Study to Examine the Effect of VX-770 on Midazolamand Rosiglitazone and the Ef ...	Cystic Fibrosis	Drug: VX-770	Vertex Pharmaceuticals Incorporated	NULL	Completed	18 Years	55 Years	Both	24	Phase 1	United States

First Previous1Next Last